Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Leukemia, Myeloid, Acute 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Melanoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Congenital Abnormalities 1Breast Neoplasms 1Blast Crisis 1

Interventions

Cyclophosphamide 71Peripheral Blood Stem Cell Transplantation 65fludarabine phosphate 62Tacrolimus 47Busulfan 47Mycophenolic Acid 39Methotrexate 39Antilymphocyte Serum 39Cyclosporine 38Whole-Body Irradiation 34Filgrastim 34Radiotherapy 32Melphalan 24Methylprednisolone 23Cord Blood Stem Cell Transplantation 22Etoposide 17Cytarabine 16Thiotepa 12Flow Cytometry 12sargramostim 10merphos 10Therapeutics 10Sirolimus 9Rituximab 9Psychiatric Rehabilitation 8Imatinib Mesylate 7thymoglobulin 6Transplantation 6Polymerase Chain Reaction 6Granulocyte Colony-Stimulating Factor 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myeloid, Accelerated Phase × alvocidib × Clear all
NCT00064285 2010-05-03

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

Virginia Commonwealth University

Phase 1 Completed
22 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡